ConductScience.org, home

Paper35565263

Impact of Levetiracetam Treatment on 5-Aminolevulinic Acid Fluorescence Expression in IDH1 Wild-Type Glioblastoma.

Wach J and 5 others. Cancers (Basel), 2022. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Impact of Levetiracetam Treatment on 5-Aminolevulinic Acid Fluorescence Expression in IDH1 Wild-Type Glioblastoma. Papers, record 35565263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35565263

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of Levetiracetam Treatment on 5-Aminolevulinic Acid Fluorescence Expression in IDH1 Wild-Type Glioblastoma.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.57
iCite
Revised in PubMed
2022-07-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wach JJohanneshttps://orcid.org/0000-0002-4680-0412
2Güresir ÁÁgi
3Hamed MMotazhttps://orcid.org/0000-0003-4828-7496
4Vatter HHartmut
5Herrlinger UUlrich
6Güresir EErdemhttps://orcid.org/0000-0001-8319-0847

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125978009A meta-analysis: Do prophylactic antiepileptic drugs in patients with brain tumors decrease the incidence of seizures?Clin Neurol Neurosurg2015https://conductscience.org/library/papers/25978009PubMed
222748650Glioblastoma multiforme treatment with clinical trials for surgical resection (aminolevulinic acid).Neurosurg Clin N Am2012https://conductscience.org/library/papers/22748650PubMed
333024247Benefits of glioma resection in the corpus callosum.Sci Rep2020https://conductscience.org/library/papers/33024247PubMed
431192128The Role of 5-ALA in Low-Grade Gliomas and the Influence of Antiepileptic Drugs on Intraoperative Fluorescence.Front Oncol2019https://conductscience.org/library/papers/31192128PubMed
526366972
The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, 18F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors.
Neurosurgery2016https://conductscience.org/library/papers/26366972PubMed
6250325433.0-T intraoperative magnetic resonance imaging-guided resection in cerebral glioma surgery: interim analysis of a prospective, randomized, triple-blind, parallel-controlled trial.Neurosurgery2014https://conductscience.org/library/papers/25032543PubMed
726544781
A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
J Neurosurg2016https://conductscience.org/library/papers/26544781PubMed
821438658Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker.J Neurosurg2011https://conductscience.org/library/papers/21438658PubMed
918667747Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.Neuro Oncol2008https://conductscience.org/library/papers/18667747PubMed
1031332208Effects of 5-aminolevulinic acid and sodium ferrous citrate on fibroblasts from individuals with mitochondrial diseases.Sci Rep2019https://conductscience.org/library/papers/31332208PubMed
1119937366The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients.J Neurooncol2010https://conductscience.org/library/papers/19937366PubMed
1216648043Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.Lancet Oncol2006https://conductscience.org/library/papers/16648043PubMed
1330018520Glioblastoma in Patients over 70 Years of Age.Radiol Oncol2018https://conductscience.org/library/papers/30018520PubMed
1418981880Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.Neurosurgery2008https://conductscience.org/library/papers/18981880PubMed
1533735464First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.Epilepsia2021https://conductscience.org/library/papers/33735464PubMed
1632612203Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy.Sci Rep2020https://conductscience.org/library/papers/32612203PubMed
1715279715Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis.Neuro Oncol2004https://conductscience.org/library/papers/15279715PubMed
1811150363Brain tumors.N Engl J Med2001https://conductscience.org/library/papers/11150363PubMed
1930790732Correlation of Ki-67 Index with Volumetric Segmentation and its Value as a Prognostic Marker in Glioblastoma.World Neurosurg2019https://conductscience.org/library/papers/30790732PubMed
2033747971Baseline Serum C-Reactive Protein and Plasma Fibrinogen-Based Score in the Prediction of Survival in Glioblastoma.Front Oncol2021https://conductscience.org/library/papers/33747971PubMed

See all 66 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
39653818Impact of levetiracetam use in glioblastoma: an individual patient-level meta-analysis assessing overall survival.Neurosurg Rev2024https://conductscience.org/library/papers/39653818PubMed
37736977
Intraoperative Fluorophores: An Update on 5-Aminolevulinic Acid and Sodium Fluorescein in Resection of Tumors of the Central Nervous System and Metastatic Lesions-A Systematic Review and Meta-Analysis.
Tomography2023https://conductscience.org/library/papers/37736977PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
FECH2235PubTator's text mininghttps://conductscience.org/library/genes/2235NCBI Gene
GFAP2670PubTator's text mininghttps://conductscience.org/library/genes/2670NCBI Gene
IDH13417PubTator's text mininghttps://conductscience.org/library/genes/3417NCBI Gene
MGMT4255PubTator's text mininghttps://conductscience.org/library/genes/4255NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35565263

GET https://conductscience.org/api/papers/v1/35565263/references?page=2